查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190339

人工耳蜗市场——增长、趋势、COVID-19 的影响、预测 (2023-2028)

Cochlear Implants Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，人工耳蜗市场预计将以 8.57% 的复合年增长率增长。

最初，COVID-19 爆发的影响对寻求康復和麵临植入技术挑战的人工耳蜗植入患者的生活影响更深。 COVID-19 的爆发扰乱了对有听力问题的人的诊断和治疗。 结果，去医院和诊所的人次减少了。 Harper L. Wilson 等人在一项名为“COVID-19 大流行对听力损失成人的沟通和医疗保健获取的影响”的研究中。用户和农村人口面临更困难的情况，例如大流行病控制和医疗保健获取，对所研究的市场产生不利影响。 评估了在大流行期间植入人工耳蜗的儿童所面临的障碍。 此类研究表明，在 COVID-19 流行期间，对人工耳蜗的需求有所下降。 它影响了人工耳蜗手术和相关服务，但也激发了新的研究努力。 然而，由于免疫接种的进展和 COVID-19 病例数量的减少，预计该市场将在预测期内充分发挥其潜力。

此外，推动市场增长的主要因素包括不断增长的老年人口中听力受损的激增、年轻人因暴露于娱乐环境中的噪音而导致听力受损的风险、人工耳蜗技术的进步和电池。这是延长寿命。

老龄化人口的听力障碍是推动市场增长的一个因素。 老年人的听力障碍负担相对较高，预计将有助于未来几年的市场增长。 例如，在 2021 年 6 月发表在 JAMA 网络上的一项题为“美国社区老年人的年龄相关性听力障碍与身体机能的关联”的研究中，参与基于人群的队列研究的美国老年人2956人中，973人（33%）听力正常，1170人（40%）轻度听力损失，692人（23%）中度听力损失，121人（4%）重度听力损失。 因此，随着老年人口的增加，人工耳蜗的需求预计会增加。 此外，听力损失和听力困难是老年人的常见问题。 根据国家聋人和困难研究所 (NIDCD) 2022 年 3 月的一份报告，在美国 65 岁至 74 岁的人中，约有三分之一的人有听力损失，75 岁及以上的人中约有一半有听力损失。它一直与。 因此，预计老龄化社会听力损失的高患病率将推动对人工耳蜗的需求，从而推动市场的扩大。

但是，主要市场参与者推出技术先进的产品将支持市场的增长。 例如，2021 年 8 月，Cochlear Limited 宣布推出 Nucleus Kanso 2 声音处理器。 此次新发布反映了科利耳 (Cochlear) 对听力技术创新的持续奉献，以提供可放大的智能手机连接访问，并帮助改善听力损失者的听力表现。 Nucleus Kanso 2 声音处理器是世界上最小的耳后式人工耳蜗声音处理器，采用听力验证技术。 此外，2021 年 2 月，Auditory Verbal United Kingdom 发起了人工耳蜗国际行动社区。 因此，所有上述因素都有望推动所研究市场的增长。 然而，这些植入物的高成本和维护难度限制了市场增长。

主要市场趋势

预计在预测期内，单侧植入部分将主导人工耳蜗市场

按类型来看，单侧植入型预计将占据主要市场份额。 与双侧植入相比，单侧植入更受青睐，主要是因为其成本效益。 例如，根据一项题为“人工耳蜗的成本效益分析”的研究，题为“人工耳蜗的成本效益分析”的研究发表如下： 2021 年 3 月在 PubMed 上发表的一份社会观点得出的结论是，对于患有进行性严重听力损失的成年人和老年人，单侧人工耳蜗的总经济效益分别为 275,000 欧元和 76,000 欧元。 即使不考虑健康益处，社会影响也是有益的，尤其是对儿童和劳动者而言。 同样，2021 年 11 月在 SpringerLink 上发表的一项题为“英国成年人单侧人工耳蜗植入的成本效益”的研究发现，儘管临床发生变化且医疗费用不断上升，但单侧人工耳蜗 (UCI) 表示它仍然具有成本效益。 在三年内，UCI 预计每年将成人和儿童植入物增加 70%，支出增加 2860 万英镑。 由于单边嵌入，此类研究和成本效率预计将在分析期间推动该细分市场的增长。

此外，技术进步以及创新产品的推出可能会在未来几年推动该细分市场的增长。 例如，2022 年 1 月，Cochlear Limited 获得美国食品和药物管理局 (US FDA) 批准用于治疗单侧听力损失 (UHL) 或单侧听力损失 (SSD) 的人工耳蜗植入物。

因此，由于上述因素，预计该行业在预测期内将出现显着增长。

预计北美将占据人工耳蜗市场的最大份额

在北美，由于美国听力损失人数的增加、植入技术的进步、人工耳蜗电池寿命的延长以及主要市场的存在等因素，美国占据了市场的领先份额业者经营，预计占据。

根据加拿大统计局 2021 年 10 月的报告，总体而言，60% 的 19 至 79 岁加拿大人有听力健康问题，包括听力损失、耳鸣或两者兼而有之。 听力损失和耳鸣在男性中尤为常见。 根据同一份文件，听力损失在加拿大老年人群中更为常见，因此，随着人口老龄化的增加，听力损失的负担预计会增加，从而刺激该地区研究市场的扩张。 此外，在北美，由于该国听力损失的高患病率和高发病率以及助听器的高采用率，预计在预测期内美国将占据助听器市场的主要市场份额。 例如，根据美国国家听力障碍研究所 2021 年 3 月的更新，在美国，每 1,000 名儿童中约有 2 至 3 名在出生时单耳或双耳有可检测到的听力损失，并且年龄在 18 岁。约占所有儿童的 15%美国成年人（3750 万）报告存在某种形式的听力损失。

此外，公司正在产品开发方面采取主动行动，以增加他们在所研究市场中的影响力。 例如，2021 年 6 月，奥迪康医疗宣布其 Neurosystem（人工耳蜗系统）专为患有双侧重度至重度感音神经性听力损失的 18 岁儿童设计，他们在正确安装助听器后效果有限。获得了上市前批准（ PMA）从美国食品和药物管理局（FDA）为以下个人。 这些新兴市场的发展预计将在不久的将来对市场增长产生积极影响。

竞争格局

人工耳蜗市场是一个综合市场，由少数参与者组成。 接受调查的市场参与者包括 MED-EL Medical Electronics、Demant A/S、Nurotron Biotechnology 和 Sonova (Advanced Bionics Corp)。 其中许多公司位于美国和欧洲。 这些地区更加发达，因此拥有更好的医疗保健资金。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 人口老龄化的听力障碍
    • 年轻人因接触娱乐性噪音而导致听力受损的风险
    • 人工耳蜗的技术进步和电池寿命的延长
  • 市场製约因素
    • 设备和维护成本高
    • 因手术受伤的风险
  • 搬运工五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（金额基础：百万美元）

  • 按类型
    • 单侧植入
    • 双侧植入
  • 最终用户
    • 儿科
    • 成人
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Cochlear Ltd（Oticon Medical）
    • MED-EL Medical Electronics
    • Nurotron Biotechnology Co Ltd
    • Sonova（Advanced Bionics Corp）
    • iotaMotion Inc.
    • Envoy Medical Corporation
    • Medtronic plc
    • Ototronix
    • Demant A/S

第7章 市场机会与今后动向

简介目录
Product Code: 66761

The Cochlear implants market is projected to register a CAGR of 8.57% during the forecast period, 2022-2027.

Initially, the impact of the COVID-19 outbreak was more profound on the lives of the cochlear implanted patients seeking habilitation and facing technical challenges with the implant. Due to COVID-19's breakout, there was a disruption in the diagnosis and treatment of people with hearing problems. As a result, fewer people visited hospitals and clinics. In the research study titled "Impacts of the COVID-19 Pandemic on Communication and Healthcare Access for Adults With Hearing Loss", by Harper L. Wilson et al in September 2021, during the COVID-19 pandemic, adult users of cochlear implants and people living in rural areas faced greater difficulties, including pandemic preparedness and access to healthcare, which has a detrimental effect on the market under study. evaluated the hurdles faced by cochlear implantee children during the pandemic. , such studies indicate that the demand for cochlear implants was reduced during the COVID-19 pandemic. Although the outbreak had an impact on cochlear implant surgery and related services, it also encouraged new research endeavors. However, the market under study is anticipated to reach its full potential over the forecast period due to ongoing vaccinations and a decline in COVID-19 cases.

Further, the major factors bolstering the market growth are the upsurge in hearing impairment in the growing geriatric population, the risk of hearing loss due to exposure to noise in recreational settings in the younger population, and technological advancements and increased battery life of cochlear implants.

Hearing impairment in the geriatric population is a major driver the market growth. The burden of hearing impairment in the older population is relatively high, and it is expected to aid the market growth over the coming years. For instance, a research study titled "Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US" published in JAMA Network, in June 2021, stated that 973 (33 %) of the 2,956 older people in United States who participated in the population-based cohort study had normal hearing, 1,170 (40%) had mild hearing impairment, 692 (23%) had moderate hearing impairment, and 121 (4%) had a severe hearing impairment. Thus, the demand for cochlear implants is expected to increase with the growing geriatric population. Moreover, hearing loss or difficulty in hearing is a common problem among older people. As per the National Institute on Deafness and Other Communication Disorders (NIDCD) report published in March 2022, approximately one in three people in United States between the ages of 65 and 74 has hearing loss and nearly half of those older than 75. As a result, the high prevalence of hearing loss among the aging population is anticipated to fuel demand for cochlear implants and thereby propel market expansion.

However, the launch of the technologically advanced product by the key market players support the market growth. For instance, In August 2021, Cochlear Limited introduced the Nucleus Kanso 2 Sound Processor. The new launch reflects Cochlear's ongoing dedication to innovation in hearing technology to provide amplifiable access to smartphone connectivity and aid in improving hearing performance in people with hearing loss. The Nucleus Kanso 2 Sound Processor is the smallest off-the-ear cochlear implant sound processor in the world with tested hearing performance technologies. Additionally, in February 2021, Auditory Verbal United Kingdom launched the Cochlear Implant International Community of Action. Thus all aforementioned factors are expected to drive the growth of the studied market. However, the high cost of these implants and the difficulty of maintenance have been restraining the market's growth.

Key Market Trends

Unilateral Implantation Segment is Expected to Dominate the Cochlear Implants Market Over the Forecast Period

By type, the unilateral implantations segment is expected to hold a major share of the market. Unilateral implantations are highly preferred compared to bilateral implantations, primarily due to their cost-effectiveness. For instance, according to a research study titled "Cost-benefit Analysis of Cochlear Implants: A Societal Perspective" published in PubMed, in March 2021, concluded that the adults and seniors with progressive severe hearing loss and unilateral cochlear implantation (CI) had a total net economic benefit of EUR 275,000 and EUR 76,000, respectively. Even without considering health advantages, the societal impact was beneficial for children and working people in particular. Similarly, a study titled "The cost-effectiveness of unilateral cochlear implants in United Kingdom adults" published in SpringerLink, in November 2021, stated that despite changes in clinical practice and rising healthcare unit costs, unilateral cochlear implants (UCIs) remain cost-effective. Within three years, UCIs are expected to boost annual implants in adults and children by 70% and spending by GBP 28.6 million. Such studies and cost efficiency offered by unilateral implantations are anticipated to boost the segment growth over the analysis period.

Moreover, technological advancements, along with innovative product launches, are likely to drive segment growth over the coming years. For instance, in January 2022, Cochlear Limited, obtained United States Food and Drug Administration (U.S. FDA) approval for Cochlear Nucleus Implants for the treatment of unilateral hearing loss (UHL) or single-sided deafness (SSD).

Thus, due to the factors mentioned above, the segment is expected to witness significant growth over the forecast period.

North America is Anticipated to Garner the Largest Share in Cochlear Implants Market

Within North America, United States is expected to hold a major share of the market owing to factors such as growth in hearing impairment among Americans, technological advancements concerning implants, increased battery life of cochlear implants, and the presence of major market players operating in the industry.

According to the October 2021 report of Statistics Canada, Overall, 60% of Canadians aged 19 to 79 had a hearing health issue, including audiometrically measured hearing loss, tinnitus, or both conditions. Hearing loss and tinnitus were particularly prevalent in men. According to the same source, hearing loss is more prevalent in older age groups in Canada; as a result, the burden of hearing loss is expected to increase as the older population grows, which is fueling the expansion of the region's studied market. Moreover, in North America, United States is expected to hold a major market share in the hearing aids market during the forecast period due to the high prevalence and incidence of hearing loss in the country and the high adoption of hearing aids. For instance, according to the March 2021 update from the National Institute on Deafness and Other Communication Disorders, about 2 to 3 out of every 1,000 children in United States were born with a detectable level of hearing loss in one or both ears, and approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing.

Furthermore, companies are taking initiatives to develop products to increase their presence in the market studied. For instance, in June 2021, Oticon Medical was granted United States Food and Drug Administration (U.S. FDA) premarket approval (PMA) for the company's Neuro System (cochlear implant system) to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from the appropriately fitted hearing aids. Such developments are likely to have a positive impact on the growth of the market in near future.

Competitive Landscape

The Cochlear Implants market is consolidated and consists of a few market players. Some of the key players in the market studied are MED-EL Medical Electronics, Demant A/S, Nurotron Biotechnology Co Ltd, and Sonova (Advanced Bionics Corp) among others. Majority of these companies are based in United States and Europe as these regions are more developed and hence better funded for healthcare.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Hearing Impairment in the Growing Geriatric Population
    • 4.2.2 Risk of Hearing Loss Due to Exposure to Noise in Recreational Settings in Younger Population
    • 4.2.3 Technological Advancements and Increased Battery Life of Cochlear Implants
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Device and Maintenance
    • 4.3.2 Risk of Injuries in Surgery
  • 4.4 Porters Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value-USD million)

  • 5.1 By Type
    • 5.1.1 Unilateral Implantation
    • 5.1.2 Bilateral Implantation
  • 5.2 By End User
    • 5.2.1 Pediatrics
    • 5.2.2 Adults
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cochlear Ltd (Oticon Medical)
    • 6.1.2 MED-EL Medical Electronics
    • 6.1.3 Nurotron Biotechnology Co Ltd
    • 6.1.4 Sonova (Advanced Bionics Corp)
    • 6.1.5 iotaMotion Inc.
    • 6.1.6 Envoy Medical Corporation
    • 6.1.7 Medtronic plc
    • 6.1.8 Ototronix
    • 6.1.9 Demant A/S

7 MARKET OPPORTUNITIES AND FUTURE TRENDS